Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Srilatha Edupuganti

2492. Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients

scholarly article by Hana M El Sahly et al published November 2018 in Open Forum Infectious Diseases

A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity

scientific article published on 3 December 2012

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

scientific article

Biphasic Zika Illness With Rash and Joint Pain

scientific article published on 22 June 2017

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

scientific article

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

scientific article published on 7 February 2011

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood

article

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

scientific article published on July 2015

Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies

scientific article

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

scientific article published on 7 May 2015

Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination

scientific article

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.

scientific article

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

scientific article published on 5 June 2015

Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification

scientific article

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

scientific article

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

scientific article

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

scientific article

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

scientific article published on October 2014

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

scientific article

Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination

scientific article

Innate, T and B Cell Responses in Acute Human Zika Patients

scientific article published on 17 August 2017

Origin and differentiation of human memory CD8 T cells after vaccination

scientific article published on 13 December 2017

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

scientific article

Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler

scientific article

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

scientific article

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

scientific article

Rapid generation of neutralizing antibody responses in COVID-19 patients

scientific article published on 08 May 2020

Recognition of influenza H3N2 variant virus by human neutralizing antibodies

scientific article published on July 2016

Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas

scientific article

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

scientific article

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

scientific article published on 08 July 2013

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

scientific article published on January 2009

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant

scientific article published on 31 January 2011

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

scientific article published on 4 December 2017

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

scientific article published on October 2014

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1

scientific article

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

scientific article

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

scientific article published on 01 June 2020

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response

scientific article

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

scientific article

Paulina is supported by:

About Paulina

Help